Chardan
Chardan is an investment bank based in New York, established in 2017. The firm specializes in providing capital market and research services, with a focus on the healthcare sector. It has been involved in facilitating various financial transactions, including mergers and acquisitions. Notably, Chardan Healthcare Acquisition Corp., a special purpose acquisition company (SPAC) created by Chardan, engaged in a reverse merger with BiomX Ltd., highlighting the firm's active role in the healthcare industry. Through its services, Chardan aims to support companies in navigating the complexities of capital markets and achieving strategic growth.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
1 past transactions
Renovacor
Post in 2021
Renovacor, Inc., established in 2013 and headquartered in Philadelphia, Pennsylvania, is a biopharmaceutical company dedicated to developing transformative gene therapies for cardiovascular diseases. Currently in the preclinical stage, Renovacor's primary focus is on creating a recombinant adeno-associated virus (AAV)-based gene therapy targeting patients with dilated cardiomyopathy (DCM) caused by mutations in the Bcl2-associated athanogene 3 (BAG3) gene. This condition affects approximately 35,000 individuals in the United States and Europe, qualifying it as an orphan disease. Renovacor aims to improve patient outcomes by potentially preventing disease progression through a BAG3 gene replacement therapy, given the current five-year survival rate of only 50% for DCM patients despite standard care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.